How Much Bacteriostatic Water for MK-677? (Chart)
Determining how much bacteriostatic water to add to MK-677 powder depends entirely on the initial mass in the vial and the target milligram-per-milliliter (mg/mL) concentration required for your laboratory protocol. Adding 2.0 mL of bacteriostatic water or target solvent to a standard 50 mg research vial yields a concentration of 25 mg/mL, whereas adding 5.0 mL yields 10 mg/mL. This guide provides exact volumetric conversion charts, mathematical calculations, and solvent handling protocols for in vitro and preclinical research applications.
Quick answer
Determining how much bacteriostatic water to add to MK-677 powder depends entirely on the initial mass in the vial and the target milligram-per-milliliter (mg/mL) concentration required for your laboratory protocol. Adding 2.0 mL of bacteriostatic water or target solvent to a standard 50 mg research vial yields a concentration of 25 mg/mL, whereas adding 5.0 mL yields 10 mg/mL. This guide provides exact volumetric conversion charts, mathematical calculations, and solvent handling protocols for in vitro and preclinical research applications.
Key takeaways
- In analytical chemistry and cell culture protocols, preparing accurate stock solutions requires strict adherence to volumetric formulas.
- The following matrix outlines standard diluent fill volumes (1.0 mL, 2.0 mL, 3.0 mL, and 5.0 mL) across common research vial masses.
- MK-677 (Ibutamoren mesylate) is a non-peptide, synthetic small-molecule ghrelin receptor agonist.
- To achieve maximum purity retention and prevent microbial contamination during liquid handling, laboratory personnel should follow standardized aseptic procedures inside a certified laminar flow hood:
Mathematical Principles of Volumetric Reconstitution for Research Solutes
In analytical chemistry and cell culture protocols, preparing accurate stock solutions requires strict adherence to volumetric formulas. The foundational equation governing liquid concentration is Concentration (C) = Mass (m) / Volume (V). When reconstituting raw solid compounds like MK-677 (Ibutamoren) for laboratory assays, researchers must pre-determine the desired working concentration before introducing any bacteriostatic water or alternative lab-grade solvent.
To quickly verify your volumetric math across various target concentrations and vial masses, utilize the PX1 reconstitution calculator. Accurate volume measurements ensure reproducible dosing in vitro and prevent mathematical skew during micro-pipetting. For instance, if an investigator requires a stock concentration of 10 mg/mL using a 100 mg vial of raw material, the required solvent volume is calculated as V = 100 mg / 10 mg/mL = 10 mL of total diluent.
Researchers should note that while many peptide compounds in our all peptides catalog require direct aqueous reconstitution with sterile preserved water, non-peptide small molecules may exhibit distinct solubility thresholds depending on solvent selection and ambient temperature. Understanding these volumetric fundamentals ensures consistent stoichiometry across cell assays.
MK-677 Reconstitution Chart: Solute Mass vs. Diluent Volume
The following matrix outlines standard diluent fill volumes (1.0 mL, 2.0 mL, 3.0 mL, and 5.0 mL) across common research vial masses. Use this reference chart to determine the resulting concentration (mg/mL) for your liquid handling systems:
• 10 mg Vial Mass: Adding 1.0 mL diluent yields 10.0 mg/mL | 2.0 mL yields 5.0 mg/mL | 3.0 mL yields 3.33 mg/mL | 5.0 mL yields 2.0 mg/mL. • 20 mg Vial Mass: Adding 1.0 mL diluent yields 20.0 mg/mL | 2.0 mL yields 10.0 mg/mL | 3.0 mL yields 6.67 mg/mL | 5.0 mL yields 4.0 mg/mL. • 50 mg Vial Mass: Adding 1.0 mL diluent yields 50.0 mg/mL | 2.0 mL yields 25.0 mg/mL | 3.0 mL yields 16.67 mg/mL | 5.0 mL yields 10.0 mg/mL. • 100 mg Vial Mass: Adding 1.0 mL diluent yields 100.0 mg/mL | 2.0 mL yields 50.0 mg/mL | 3.0 mL yields 33.33 mg/mL | 5.0 mL yields 20.0 mg/mL.
When planning high-throughput assays, selecting a fill volume that results in an easily divisible concentration (such as 10 mg/mL or 25 mg/mL) significantly reduces pipetting errors. For pre-formulated solid research forms designed for standardized oral secretagogue evaluations in animal models, researchers may also reference MK-677 capsules (12.5 mg) to bypass liquid solubilization steps.
Solubility Profiles: Bacteriostatic Water vs. Organic Co-Solvents
MK-677 (Ibutamoren mesylate) is a non-peptide, synthetic small-molecule ghrelin receptor agonist. Unlike classic short-chain peptides, its chemical structure contains hydrophobic functional groups that alter its thermodynamic dissolution behavior. While bacteriostatic water containing 0.9% benzyl alcohol is the standard diluent for hydrophilic peptides, raw MK-677 powder exhibits selective solubility characteristics dependent on pH and solvent dielectric constants.
In vitro data indicate that while MK-677 mesylate salts dissolve in aqueous environments up to specific saturation limits, higher concentrations (>25 mg/mL) often require initial dissolution in organic co-solvents such as polyethylene glycol (PEG-400), dimethyl sulfoxide (DMSO), or ethanol prior to final dilution with bacteriostatic water. Attempting to dissolve high mass quantities directly into pure aqueous bacteriostatic water without a co-solvent may lead to persistent precipitate formation or cloudiness.
For aqueous cell culture media compatibility, investigators frequently prepare a concentrated primary stock solution in DMSO or PEG-400, followed by secondary working dilutions in sterile preserved water or saline buffer. This technique ensures complete chemical dissolution without compromising cellular viability in culture models.
Step-by-Step Reconstitution Protocol for Laboratory Settings
To achieve maximum purity retention and prevent microbial contamination during liquid handling, laboratory personnel should follow standardized aseptic procedures inside a certified laminar flow hood:
1. Sanitization: Disinfect the rubber stopper of the raw compound vial and the seal of the bacteriostatic water container using 70% isopropyl alcohol wipes. Allow surfaces to air-dry completely. 2. Pressure Equalization: Using a sterile analytical syringe, draw a volume of air equal to the target diluent volume (e.g., 2.0 mL) and inject it into the diluent vial to equalize internal pressure. 3. Diluent Transfer: Withdraw the exact volume of bacteriostatic water or solvent mixture required according to your target concentration calculations. 4. Reconstitution: Direct the syringe needle toward the glass inner wall of the target vial rather than spraying directly onto the dry lyophilized powder. Slowly depress the plunger to minimize turbulence and aerosol formation. 5. Solubilization: Gently swirl the vial in a circular motion at ambient temperature. Avoid aggressive agitation or mechanical vortexing, which can introduce microscopic air bubbles or force precipitation out of solution.
If residual particulate remains visible after 5 minutes of gentle swirling, incubate the vial in a low-temperature water bath (25°C to 30°C) for brief intervals, or evaluate whether a co-solvent addition is required for the chosen concentration.
Pharmacological Mechanism: Ghrelin Receptor Activation in Preclinical Models
MK-677 operates as an orally active, potent, non-peptide growth hormone secretagogue (GHS). Preclinical studies suggest that MK-677 selectively targets and activates the growth hormone secretagogue receptor (GHSR-1a), mimicking the endogeneous ligand ghrelin. This receptor binding cascade triggers a signal transduction pathway that stimulates the anterior pituitary gland to release growth hormone (GH) in a pulsatile manner.
Unlike direct recombinant growth hormone administration, in vitro and rodent model data demonstrate that GHSR-1a activation by MK-677 preserves the physiological feedback mechanisms of the hypothalamic-pituitary axis. Consequently, downstream circulating levels of insulin-like growth factor 1 (IGF-1) undergo sustained elevation without altering basal cortisol or prolactin concentrations under controlled research conditions.
Researchers evaluating somatotropic signaling pathways frequently utilize MK-677 to study nitrogen retention, body composition changes, bone mineral density dynamics, and cellular repair processes in preclinical animal models. Access comprehensive analytical profiles and documentation for these investigations via the PX1 research hub.
Aliquoting Guidance and Chemical Stability Metrics
Once reconstituted into liquid form, raw research compounds are subject to chemical degradation pathways such as hydrolysis and oxidation over extended timelines. To preserve compound integrity across multi-week assay schedules, establishing an aliquoting protocol is strongly recommended.
Dividing the main reconstituted solution into smaller micro-centrifuge tubes (e.g., 0.5 mL to 1.0 mL single-use aliquots) minimizes the degradation caused by repeated thermal cycling and repeated stopper punctures. Aliquots designated for immediate use within 14–28 days should be stored at 2°C to 8°C inside a dark, temperature-monitored laboratory refrigerator.
For long-term preservation spanning several months, un-diluted dry raw powder or frozen non-aqueous stock aliquots should be stored at -20°C or -80°C. Avoid subject freezing and thawing cycles for aqueous-based mixtures, as ice crystal formation can alter local solute concentrations and induce compound precipitation out of solution.
Comparative Analysis: MK-677 vs. Peptide-Based GH Secretagogues
When designing preclinical protocols investigating the somatotropic axis, researchers often compare MK-677 against classical peptide-based secretagogues such as Ipamorelin and CJC-1295 DAC. Understanding the structural and mechanistic differences between these classes is critical for selecting the appropriate experimental model.
MK-677 is an orally bioavailable small-molecule agonist of the ghrelin receptor (GHSR-1a) with an extended half-life in rodent models (~24 hours). In contrast, Ipamorelin is a pentapeptide that selectively targets GHSR-1a with high specificity but exhibits a significantly shorter biological half-life, requiring frequent liquid administration in animal protocols. Meanwhile, CJC-1295 DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) that binds to GHRH receptors rather than ghrelin receptors, utilizing Drug Affinity Complex technology to prolong plasma persistence.
Because MK-677 is a non-peptide small molecule, its solubility and reconstitution properties differ markedly from injectable peptide chains. While peptides readily dissolve in pure aqueous bacteriostatic water, MK-677 raw powder requires careful attention to solvent selection (co-solvents like PEG-400 or DMSO) to maintain long-term solution stability at high concentrations.
PX1 Research Quality Assurance, HPLC Verification, and Compliance
Rigorous scientific research demands baseline consistency and absolute solvent purity. PX1 Research supplies high-grade research compounds manufactured in state-of-the-art facilities located entirely within the USA. Every lot produced undergoes stringent analytical testing to guarantee experimental reproducibility.
We utilize high-performance liquid chromatography (HPLC) coupled with mass spectrometry (MS) to confirm identity, molecular weight, and purity levels exceeding 99.0%. Furthermore, all compound batches undergo strict endotoxin testing in ISO 17025 accredited laboratories to ensure suitability for sensitive cellular assays and in vitro systems. Researchers can independently examine lot-specific documentation by visiting our transparent Certificate of Analysis (COA) portal.
Whether sourcing single reference vials or securing institutional quantities through our dedicated wholesale laboratory accounts, PX1 Research fulfills orders with fast, same-day dispatch from our California and Arizona fulfillment centers. All products are strictly intended for laboratory research use only.
Frequently Asked Questions
How much bacteriostatic water should be added to a 50 mg vial of MK-677?
Adding 2.0 mL of diluent to a 50 mg vial produces a concentration of 25 mg/mL, whereas adding 5.0 mL produces a concentration of 10 mg/mL. The chosen volume depends on your required assay concentration.
Is raw MK-677 powder completely soluble in pure bacteriostatic water?
MK-677 mesylate is moderately soluble in water, but high concentrations (>20–25 mg/mL) often require a co-solvent such as PEG-400, DMSO, or ethanol prior to final dilution with bacteriostatic water to prevent precipitation.
Where can I verify the purity batch report for PX1 research compounds?
Lot-specific analytical data, including HPLC chromatograms, mass spectrometry results, and endotoxin screens, can be accessed directly on our COA page at /coa.
How does MK-677 compare to peptide GH secretagogues like Ipamorelin?
MK-677 is an orally active non-peptide small molecule that targets ghrelin receptors with a long half-life (~24 h), whereas Ipamorelin is a peptide secretagogue with a shorter half-life requiring aqueous reconstitutions.
How should reconstituted MK-677 solutions be stored in the lab?
Reconstituted liquid stock solutions should be aliquoted and stored at 2°C to 8°C for short-term use (up to 28 days) or frozen at -20°C for extended stability, protected from direct light exposure.
Can I use the PX1 reconstitution calculator for small-molecule solutions?
Yes. The PX1 reconstitution calculator computes volumetric math (mass vs. volume) for any research solute, regardless of whether it is a small molecule or a peptide chain.
What endotoxin standards apply to PX1 research materials?
All PX1 research lots undergo USP <85> bacterial endotoxin testing in ISO 17025 accredited facilities to guarantee low endotoxin levels suitable for in vitro assays.
Why is aliquoting recommended after reconstituting research compounds?
Aliquoting prevents degradation caused by repeated freeze-thaw cycles, light exposure, and potential microbial introduction from repeated syringe punctures into a single vial stopper.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.